|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 196.52 USD | +0.52% |
|
-2.32% | +11.67% |
| 02-13 | Biogen Inc. Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium, Feb-13-2026 10:30 AM | |
| 02-12 | Analyst recommendations: Pfizer, Applovin, Biogen, Hilton, Snap… |  |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 201.18 | 201.18 | 201.18 |
| Spread/Res. | -2.32% | -2.32% | -2.32% |
| Spread/Supp. | +9.24% | +19.52% | +30.68% |
| Support | 179.89 | 164.42 | 150.38 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- BIIB Stock
- Charts Biogen Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition